Free Trial

SeaStar Medical Q4 2024 Earnings Report

SeaStar Medical logo
$1.36 +0.01 (+0.81%)
As of 02:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SeaStar Medical EPS Results

Actual EPS
-$0.90
Consensus EPS
-$0.89
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

SeaStar Medical Revenue Results

Actual Revenue
$0.07 million
Expected Revenue
$0.15 million
Beat/Miss
Missed by -$83.00 thousand
YoY Revenue Growth
N/A

SeaStar Medical Announcement Details

Quarter
Q4 2024
Time
After Market Closes

Conference Call Resources

Remove Ads

SeaStar Medical Earnings Headlines

Q4 2024 SeaStar Medical Holding Corp Earnings Call
Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
See More SeaStar Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SeaStar Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SeaStar Medical and other key companies, straight to your email.

About SeaStar Medical

SeaStar Medical (NASDAQ:ICU), a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

View SeaStar Medical Profile

More Earnings Resources from MarketBeat